Extended 10-Panel
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.
A 2C-B urine test is a qualitative screening that detects the presence of 2C-B (4-bromo-2,5-dimethoxyphenethylamine) or its metabolites in urine. 2C-B is a synthetic psychedelic phenethylamine with stimulant and hallucinogenic properties.
Doctor's Assessment Included
This test detects the presence of 2C-B and its metabolites in urine. 2C-B is a synthetic phenethylamine compound that is not detected by standard drug screening panels. The test provides a qualitative result indicating whether 2C-B metabolites are present above the assay cut-off level.
Because 2C-B is structurally distinct from other commonly screened substances, a targeted assay is required for reliable detection.
Detection of 2C-B may be relevant for clinical assessment, forensic investigations, and extended drug screening programmes. The substance is not included in standard workplace drug panels, making targeted testing important when its use is suspected.
Accurate identification supports appropriate clinical decision-making and helps distinguish 2C-B from other phenethylamine derivatives.
Testing may be relevant when 2C-B use is suspected, as part of extended drug screening panels, or during forensic evaluations. Standard immunoassay panels do not detect 2C-B.
Consult a healthcare professional for guidance on when testing is appropriate and how to interpret results.
2C-B may be detectable in urine for approximately 1 to 3 days after use. The detection window can vary depending on dosage, individual metabolism, and hydration levels. Consult a healthcare professional for more details.
No, 2C-B is not included in standard workplace drug screening panels such as the 5-panel or 10-panel tests. A specific, targeted assay using techniques such as mass spectrometry is required for detection.
The test involves providing a urine sample, which is analysed for the presence of 2C-B metabolites. Results are qualitative, indicating whether the substance is detected above the assay threshold. Confirmatory testing may be performed if the initial screening is positive.
These panels measure values from the same category as this marker.
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.
Screen for 5 commonly requested substances including CDT, cocaine, ketamine, amphetamines, and 3-MMC.
Individual cocaine metabolite screening with laboratory confirmation.
A CDT test measures chronic alcohol use over recent weeks. The Dutch guideline sets the cut-off at 2.0%.
Medical reviewer
Dr. Naimi oversees the medical standards behind our content and assessments.
Medical policyDoctor's Assessment Included
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
2C-B
€146,-
We use cookies to analyze site usage and measure ad effectiveness. Privacy Policy